Introduction
Among the different Acinetobacter species, Acinetobacter baumannii is an important nosocomial pathogen with the ability to cause infection outbreaks (1) (2) (3) . Potential risk factors associated with the development of colonization or infection of hospitalized patients with Acinetobacter spp. include prolonged length of hospital stay, severity of underlying disease, invasive procedures and treatment (mechanical ventilation, urinary catheterization, parenteral nutrition), exposure to broad-spectrum antimicrobial agents such as carbapenems or third-generation cephalosporins, primary and acquired immunodeficiency, and age (4, 5) .
A wide range of class A beta-lactamases, including the narrow-spectrum, extended-spectrum, and carbapenemhydrolyzing variants, have been identified in all species of Acinetobacter such as A. calcoaceticus, A. baumannii, A. gerneri, and others (6) .
OXA enzymes encoded by bla OXA genes can be subclassified into four distinct subgroups, of which bla , bla , bla , and bla have been identified in Acinetobacter spp. (6) . In some countries bla and bla are the most prevalent oxacillinases, like in Poland (1), Iran (7) , and Ireland (8) , while in some countries bla and bla are the most prevalent, as in Saudi Arabia (9), Croatia (10), and Italy (11) .
Antibiotic resistance in Acinetobacter spp. has been previously reported from Bosnia and Herzegovina in 4.5% of isolates causing blood infections with multidrug resistance rates of 45%-85% (12) , but the molecular characteristics have not been described.
The aim of this study was to investigate the molecular characteristics and antibiotic resistance of infections caused by Acinetobacter baumannii producing beta-lactamases/ extended-spectrum beta-lactamases (ESBLs) or oxacillinases.
Materials and methods

Setting, bacterial isolates, and study design
All consecutive, nonduplicate Acinetobacter spp. isolates resistant to expanded-spectrum cephalosporins included in the analysis were collected from various specimens and various hospital departments, including the outpatient department, in the period between December 2009 and May 2010.
Information records for study patients consisted of age, sex, occupation, place of residence at time of admission to the hospital (e.g., at home, other hospital, nursing home), contact with person(s) with history of hospitalization in the past 12 months, hospital department, surgery during a stay in the hospital, antibiotics usage in the past 4 months, and glucocorticoid therapy.
Institutional review board approval of the Ethics Committee of the Cantonal Hospital Zenica was obtained prior to the initiation of the study.
Susceptibility testing
Antimicrobial susceptibility testing was performed by a twofold microdilution technique according to the standard Clinical and Laboratory Standards Institute (CLSI) procedure (13) with amoxicillin + clavulanic acid, ceftazidime, cefotaxime, ceftriaxone, cefepime, imipenem, meropenem, gentamicin, and ciprofloxacin. The following MIC resistance breakpoints were used: ≥32 for amoxicillin/ clavulanic, ceftazidime, and cefepime; ≥64 for cefotaxime and ceftriaxone; ≥16 for imipenem and meropenem; ≥8 for gentamicin; and ≥4 for ciprofloxacin. Escherichia coli ATCC 25922 (ESBL-negative) and Klebsiella pneumoniae 700603 (ESBL-positive) were used as quality control strains.
Detection of ESBLs
A double-disk synergy test using the combination of amoxicillin/clavulanate with cefotaxime, ceftriaxone, ceftazidime, and cefepime was performed in order to detect the production of ESBLs. Distortion of the inhibition zones around cephalosporin disks towards the central disk was considered as a positive result (14) . Production of ESBLs was confirmed by CLSI combined disk test.
Phenotypic detection of carbapenemases
Production of group A or group B carbapenemases was confirmed by combined disk test using EDTA and PBA. The augmentation of the inhibition zones around disks with PBA for at least 5 mm was suggestive of KPC production while the increase of the inhibition zones around disks with EDTA indicated MBL production (15).
Molecular characterization of ESBL
Polymerase chain reaction (PCR) was used to detect alleles encoding ESBL enzymes. The presence of bla TEM , bla SHV , and bla CTX-M genes was investigated by PCR using primers and conditions as described previously (16) .
Template DNA was extracted by the boiling method. PCR mix (50 µL) contained 25 µL of master mix (Roche), 20 µL of ultrapure water, 1 µL of each primer (10 pmol), and 3 µL of the template DNA. Strains positive for CTX-M beta-lactamases were further tested by multiplex PCR with primers specific for CTX-M groups 1, 2, 8, 9, and 25 (16) . Amplicons were column-purified (QIAGEN DNA purification kit) and sequenced directly using the ABI PRISM 377 Genetic Analyzer (Applied Biosystems). Sequences were analyzed using BioEdit v.7.0.9 (Ibis Biosciences). Designation of bla genes based on the identified mutations was done according to a previous study based on amino acid sequences for TEM, SHV, and OXA extended-spectrum and inhibitor-resistant β-lactamases (17).
Molecular detection of carbapenemases
Genes encoding carbapenemases of group A (KPC), group B (MBLs belonging to the VIM, IMP, and NDM family), and OXA-48 were detected by PCR as described previously (1,18).
Molecular detection of oxacillinases
All isolates were subjected to multiplex PCR to detect the bla OXA-51 , bla OXA-23 , bla OXA-24 , bla OXA-58 , and bla OXA-143 genes (19).
Results
Clinical specimens
In the period between December 2009 and May 2010, of a total of 1254 inpatient gram-negative bacteria samples and 2857 outpatient, 45 (3.9%) and 22 (0.8%) were identified as Acinetobacter spp., respectively.
Among inpatient samples, ten (22.2%) A. baumannii produced beta-lactamases or ESBLs or oxacillinases, of which 30.0% were from skin and soft tissue infections, 20.0% from surgical wounds, 20.0% from cannulae, and 10.0% from each sample of burn, stoma, and ear.
Among outpatient samples, three (13.6%) were betalactamases or ESBLs or oxacillinases, of which 66.7% were from surgical wounds and 33.3% from genital swabs.
More than half of both the inpatients and outpatients with infections caused by A. baumannii were male (n = 10; 76.9%) ( Table 1 ). Mean patient age was 46 years (minimum: <1, maximum: 78). Duration of hospitalization (median) was 12 days (range: 8-23), excluding one case where the duration of hospitalization was 23 days (Table 1) . Table 2 shows the susceptibility of 13 A. baumannii isolates tested with twofold microdilution. Thirteen isolates were resistant to imipenem and four (out of 13; 30.8%) isolates were resistant to meropenem. The resistance rate to gentamicin was 84.6%. Prevalence of resistance to ceftazidime, cefotaxime, ceftriaxone, and cefepime was in the range of 75% to 92%.
Antibiotic susceptibility
Detection and characterization of β-lactamases
Seven A. baumannii isolates carried bla TEM , of which four isolates coproduced bla OXA-51 , while the other isolates produced TEM along with CTX-M, OXA-1, or OXA-51. Three (23.1%) isolates carried a bla CTX-M group 1 betalactamase (Table 1) .
Thirteen oxacillinase-positive isolates carried bla OXA-51 (Table 1) . PCR was negative for bla , bla , bla OXA-58 , and bla . PCR was also negative for bla IPM , bla VIM , bla SPM , bla GIM , bla SIM , and bla NDM .
Discussion
Acinetobacter spp. has emerged as one of the most important pathogens involved in healthcare-associated infections in the recent decades (3). Production of β-lactamases is one of the most important resistance mechanisms of many bacterial species (20) . In the present study, the prevalence of beta-lactamases/ESBLs or oxacillinases in Acinetobacter spp. isolates of 22.2% of inpatients and 14% of outpatients, respectively, was found. The prevalence of β-lactamases in Acinetobacter isolates found in this study is lower than that (8, 18) . The resistance rate of A. baumannii isolates to different antibiotics in this study was high. This is similar to a report from Turkey (22) as a piperacillin-tazobactam and meropenem susceptibility rate of 50% and 70%, respectively, was found in this study. These agents are the most effective β-lactams against Acinetobacter isolates, and this finding is similar to a report from Tehran (7). According to the results of this study, the first-line therapy drugs used in hospital departments were amoxicillin/ clavulanic and imipenem, β-lactam/β-lactamase-inhibitor combinations. Similarly, Boo et al. reported administration of amoxicillin/clavulanic and meropenem as the firstline therapy for the treatment of infections caused by Acinetobacter spp. (8) .
In recent years, the number of Acinetobacter isolates showing resistance to imipenem has been increasing (7). One of the possible reasons for the high prevalence of imipenem resistance of A. baumannii in this study is the presence of OXA-carbapenemases (intrinsic bla OXA-51 in 100% of isolates, or deficiency in porin or reduced expression of outer membrane proteins that was found). The present results support previous ones, suggesting that bla OXA-51 is species-specific to A. baumannii (23) . This study has not detected any other acquired oxacillinases, e.g., bla OXA-23 , bla OXA-24 , bla OXA-58 , or bla OXA-143 , except intrinsic bla OXA-51 . This is in contrast to reports from Poland with bla OXA-23 and bla in 45% of cases (1); Iran with bla and bla OXA-24 in 20% (7); Ireland with bla OXA-23 in 10% (8); Saudi Arabia with bla OXA-23 and bla OXA-58 in 100% and 2% (9); and Croatia with bla OXA-58 , bla OXA-24 , and bla in 33%, 27%, and 9% (10) . Some authors reported that ISAbaI (insertion sequence, A. baumannii), which is adjacent to bla OXA-51 , plays a major role in the development of resistance to carbapenems (24) . In previous studies, imipenem resistance was associated only with isolates in which ISAbaI was upstream of bla OXA-51 , suggesting that ISAbaI provides the promoter for this gene (24) . One isolate in this study was positive for ISAbaI, resulting in a low prevalence, and this is similar to a Norwegian study (18) . The relationship between bla OXA-51 and the resistance of A. baumannii isolates to imipenem still needs to be investigated. This study found a high prevalence of multidrug resistance of 54% in A. baumannii, limiting the appropriate treatment of infections caused by Acinetobacter spp. isolates. Seven isolates coproduced TEM, CTX-M, OXA-1, or OXA-51 beta-lactamases, which is in concordance with other reports (3).
Almost all patients were immunocompromised, predisposing for an infection with Acinetobacter spp. (25) . Similarly to other reports, carbapenemase-producing gram-negative bacteria could cause a wide spectrum of infections including bacteremia, nosocomial pneumonia, wound infections, endocarditis, and urinary tract infections (25) . Those infections are often associated with treatment failure, long hospital stay, and high mortality rates (25) .
The main mode of transmission of genes is between patients via the hands of healthcare workers, although ESBL outbreak has been attributed to contaminated medical devices, too (e.g., ultrasound gel) (26) . Thus, hand hygiene should be the most effective preventive measure (26) . Contact precautions in addition to other infection prevention measures, e.g., environmental cleaning, use of gloves and aprons/gowns, or restriction of antibiotics, have been shown to be effective in preventing transmission in outbreak situations (26) .
A surveillance of antimicrobial resistance in Bosnia and Herzegovina, which should be the first step toward appropriate control of antibiotic usage, does not exist. There are still debates about optimizing possible treatment approaches in infections caused by carbapenemaseproducing strains (27) . It is strongly suggested that combination therapy, including colistin, tigecycline, aminoglycosides, aztreonam, and carbapenems in different combination schemes, is still superior to monotherapy and that carbapenem-containing regimens are superior to others when an appropriate dose is applied (25) . Active surveillance, hand hygiene, contact precautions, and appropriate antibiotic usage should be a part of the effective approach to reducing the incidence of colonization and infections caused by these lifethreatening microorganisms.
Our study has several limitations. The first is the small number of A. baumannii isolates collected in a period of 6 months, but, on the other hand, we have a low prevalence of these isolates causing hospital and community infections. One of the limitations is that pulsed-field gel electrophoresis was not done for the isolates, which creates a problem in the interpretation of the mode of gene transfer. In the future, it would be good to conduct research about the mechanisms of resistance in Acinetobacter spp. isolates collected from hospital and community settings.
In conclusion, the production of bla OXA-51 presents an emerging threat in imipenem-resistant Acinetobacter spp. from Bosnia and Herzegovina. Results regarding molecular characteristics and antimicrobial resistance among Acinetobacter strains are limited while reduced susceptibility to these agents is a matter of increasing clinical concern worldwide. Molecular characterization and strain typing of such epidemic bacteria are important for the detection of the sources and mode of spread, which is the main step in order to design targeted infection control strategies. Further studies are required in order to monitor mechanisms of resistance levels among A. baumannii strains.
